CEO, TELESIS BIO
Dr. Todd Nelson has guided several life science companies through expansive phases of financial and commercial growth. From 2014 to 2017, Dr. Nelson served as CEO of DiscoverX, a leading developer and manufacturer of reagents intended for drug discovery. From 2011 to 2014, he led MP Biomedicals and between 2007 and 2011, served as CEO of eBioscience. In October 2022, he oversaw the name change from Codex DNA to Telesis Bio
